KeyZell is a Spanish startup that has managed to combine biotechnology with mathematics and develop in a pioneering manner artificial intelligence systems for the diagnosis and treatment of different types of cancer.
The AI Diagnosis tool allows to improve the accuracy of cancer diagnosis by imaging through a rapid X-ray test. It is currently working with other tests such as positron emission tomography known as PET and DICOM standards.
The Oncology Precision System is the first validated precision medicine system aimed at identifying patterns and making predictions to help oncologists choose the best treatment and therapies based on the patients unique characteristics.
With a presence in Mexico, Australia and Thailand, KeyZell is also focused on the advancement of new anticancer drugs that will provide solutions against tumor cell proliferation and metastasis production.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is KeyZell in?
KeyZell operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is KeyZell based?
KeyZell is headquartered in Sevilla, Spain.
Find investors for your startup like KeyZell
Gritt sends AI-personalised outreach to each investor — from your Gmail
